Summit Therapeutics plc (SMMT): Price and Financial Metrics
SMMT Price/Volume Stats
| Current price | $20.76 | 52-week high | $36.91 |
| Prev. close | $19.73 | 52-week low | $6.78 |
| Day low | $19.82 | Volume | 2,925,432 |
| Day high | $21.20 | Avg. volume | 3,743,652 |
| 50-day MA | $23.29 | Dividend yield | N/A |
| 200-day MA | $20.51 | Market Cap | 15.42B |
SMMT Stock Price Chart Interactive Chart >
Summit Therapeutics plc (SMMT) Company Bio
Summit Therapeutics plc operates as a biopharmaceutical company primarily in the United Kingdom and the Unites States. It focuses on the discovery, development, and commercialization of novel medicines to treat the Duchenne Muscular Dystrophy (DMD), a fatal muscle wasting disease; and infections caused by Clostridium difficile bacteria (CDI). The company was founded in 2003 and is based in Abingdon, England.
SMMT Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SMMT Price Returns
| 1-mo | -14.53% |
| 3-mo | 16.76% |
| 6-mo | 11.97% |
| 1-year | 155.35% |
| 3-year | 1,935.29% |
| 5-year | 489.77% |
| YTD | 16.34% |
| 2024 | 583.72% |
| 2023 | -38.59% |
| 2022 | 57.99% |
| 2021 | -42.77% |
| 2020 | 193.75% |